Structured evidence table for Echinacea Immune Support Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Echinacea Immune Support Meta-Analysis | The present review focuses onanddue to the exceptional breadth of mechanistic, formulation-based, and clinical evidence available for these two species, rather than implying exclusivity in their biological relevance. | 3 | Espinoza Juan Pablo (2026) | Pharmacological Insights and Technological Innovations in Curcuma longa L. and Echinacea purpurea (L.) Moench as Plant-Derived Immunomodulators |
| Echinacea Immune Support Meta-Analysis | purpurea 7 8 Despite increasing scientific evidence supporting the benefits of curcuminoids fromand of caffeic acid derivatives and alkylamides from, several challenges hinder their clinical translation. | 3 | Espinoza Juan Pablo (2026) | Pharmacological Insights and Technological Innovations in Curcuma longa L. and Echinacea purpurea (L.) Moench as Plant-Derived Immunomodulators |
| Echinacea Immune Support Meta-Analysis | Case series from Drug-Induced Liver Injury (DILI) registries and individual reports now describe acute drug-induced liver injury associated with turmeric or curcumin supplements, particularly products co-formulated with the bioenhancer piperine or other agents that markedly increase systemic exposure. | 3 | Espinoza Juan Pablo (2026) | Pharmacological Insights and Technological Innovations in Curcuma longa L. and Echinacea purpurea (L.) Moench as Plant-Derived Immunomodulators |
| Echinacea Immune Support Meta-Analysis | 1 2 3 4 Curcuma longa Echinacea purpurea Moench Andrographis paniculata Astragalus Nigella sativa Zingiber officinale Glycyrrhiza glabra Lentinula edodes C. | 3 | Espinoza Juan Pablo (2026) | Pharmacological Insights and Technological Innovations in Curcuma longa L. and Echinacea purpurea (L.) Moench as Plant-Derived Immunomodulators |
| Echinacea Immune Support Meta-Analysis | Autoimmune diseases have shown an annual global incidence increase of 19.1% over the past 30 years [], while type 2 diabetes, now affecting over 800 million adults worldwide [], is strongly associated with immune dysfunction, impairing the body’s ability to combat infections effectively. | 3 | Trivadila Trivadila (2025) | Herbal Immunostimulants and Their Phytochemicals: Exploring Morinda citrifolia , Echinacea purpurea , and Phyllanthus niruri |
| Echinacea Immune Support Meta-Analysis | While immunomodulatory drugs like corticosteroids and monoclonal antibodies effectively regulate immune responses in conditions such as autoimmune and inflammatory diseases, they often induce immunosuppression, increasing infection risk by enhancing viral shedding and replication, which delays pathogen clearance []. | 3 | Trivadila Trivadila (2025) | Herbal Immunostimulants and Their Phytochemicals: Exploring Morinda citrifolia , Echinacea purpurea , and Phyllanthus niruri |
| Echinacea Immune Support Meta-Analysis | These effects are attributed to the rich diversity of bioactive compounds found in plants, including flavonoids, alkaloids, polysaccharides, terpenoids, and phenolic acids. | 3 | Trivadila Trivadila (2025) | Herbal Immunostimulants and Their Phytochemicals: Exploring Morinda citrifolia , Echinacea purpurea , and Phyllanthus niruri |
| Echinacea Immune Support Meta-Analysis | 1 2 3 4 5 The increasing prevalence of infectious diseases and immune-related disorders presents significant global health challenges. | 3 | Trivadila Trivadila (2025) | Herbal Immunostimulants and Their Phytochemicals: Exploring Morinda citrifolia , Echinacea purpurea , and Phyllanthus niruri |
Source documents